scispace - formally typeset
B

Barış Ata Borsa

Researcher at Linköping University

Publications -  20
Citations -  324

Barış Ata Borsa is an academic researcher from Linköping University. The author has contributed to research in topics: Antibiotics & Nanocapsules. The author has an hindex of 6, co-authored 20 publications receiving 230 citations. Previous affiliations of Barış Ata Borsa include Istanbul University & Istanbul Kemerburgaz University.

Papers
More filters
Journal ArticleDOI

Staphylococcus aureus detection in blood samples by silica nanoparticle-oligonucleotides conjugates

TL;DR: A fast, specific and sensitive homogeneous assay for Staphylococcus aureus detection was developed by measuring the activity of secreted nuclease from the bacteria via a modified DNA oligonucleotide, formed by nucleic acid oligos and magnetic or mesoporous silica nanoparticles.
Journal ArticleDOI

Antibiotic loaded nanocapsules functionalized with aptamer gates for targeted destruction of pathogens

TL;DR: Aptamer-gates caused a specific decrease in minimum inhibitory concentration values of vancomycin for Staphylococcus aureus when mesoporous silica nanoparticles (MSNs) were used for bacteria-targeted delivery.
Journal ArticleDOI

Hierarchically porous polymer derived ceramics: A promising platform for multidrug delivery systems

TL;DR: In this paper, mesoporous silicon oxycarbide (SiOC) components were formed with the use of "molecular spacer" (a sacrificial vinyl-terminated linear siloxane which while decomposing during pyrolysis generates pores with size proportional to the molecular weight), followed by a post-pyrolyisation etching treatment by hydrofluoric acid (HF) to obtain C-rich SiOC samples having additional micro-/mesoporosity and specific surface area reaching to 774m2/g.
Journal ArticleDOI

The relationship between bifidobacteria and allergic asthma and/or allergic dermatitis: a prospective study of 0-3 years-old children in Turkey.

TL;DR: It is proposed that the production of probiotics in accordance with country-specific Bifidobacterium species densities would improve public health and country- specific prospective case-control studies that collect broad data sets are needed.
Journal ArticleDOI

Inhibitory effects of aptamer targeted teicoplanin encapsulated PLGA nanoparticles for Staphylococcus aureus strains

TL;DR: Teicoplanin delivery nanoparticles of Poly Lactic-co-Glycolic Acid (PLGA), which are functionalized with S. aureus specific aptamers, can be an attractive alternative to combat with some of the multi-drug resistant bacterial pathogens.